These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1597847)

  • 21. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
    Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure to a moderate intensity static magnetic field enhances the hypotensive effect of a calcium channel blocker in spontaneously hypertensive rats.
    Okano H; Ohkubo C
    Bioelectromagnetics; 2005 Dec; 26(8):611-23. PubMed ID: 16189831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum concentrations and effects of (+/-)-nicardipine compared with nifedipine in a population of healthy subjects.
    Porchet HC; Dayer P
    Clin Pharmacol Ther; 1990 Aug; 48(2):155-60. PubMed ID: 2199131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of uraemia on the hepatic clearance and metabolism of nicardipine.
    Ahmed JH; Grant AC; Rodger RS; Murray GR; Elliott HL
    Br J Clin Pharmacol; 1991 Jul; 32(1):57-62. PubMed ID: 1888642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parotitis due to nicardipine.
    Bosch X; Sobrino J; Lopez-Soto A; Urbano-Marquez A
    BMJ; 1992 Apr; 304(6831):882. PubMed ID: 1392752
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pseudoalcoholic hepatitis during treatment with nicardipine].
    Isoard B; Daumont M; Pousset G; Paliard P
    Presse Med; 1988 Apr; 17(13):647-8. PubMed ID: 2966941
    [No Abstract]   [Full Text] [Related]  

  • 27. Ciclosporin-nicardipine interaction.
    Deray G; Aupetit B; Martinez F; Baumelou A; Worcel A; Benhmida M; Legrand JC; Jacobs C
    Am J Nephrol; 1989; 9(4):349. PubMed ID: 2817022
    [No Abstract]   [Full Text] [Related]  

  • 28. Erythromelalgia induced by nicardipine.
    Levesque H; Moore N
    BMJ; 1989 Jul; 299(6694):323. PubMed ID: 2504422
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythromelalgia induced by nicardipine.
    Drenth JP
    BMJ; 1989 Jun; 298(6687):1582. PubMed ID: 2503135
    [No Abstract]   [Full Text] [Related]  

  • 30. Some metabolic changes following prolonged moderate exercise.
    PASSMORE R; JOHNSON RE
    Metabolism; 1960 May; 9():452-5. PubMed ID: 14430745
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of fasting on physiological responses to exercise in non-obese women.
    Avakian EV; Horvath SM; McCafferty WB
    J Sports Med Phys Fitness; 1987 Sep; 27(3):303-9. PubMed ID: 3431113
    [No Abstract]   [Full Text] [Related]  

  • 32. Nutrition and physical performance. The metabolic effects of exercise.
    Harris P
    Proc Nutr Soc; 1966; 25(2):91-3. PubMed ID: 5911966
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic Catch-22 of exercise regimens.
    Kolata G
    Science; 1987 Apr; 236(4798):146-7. PubMed ID: 3563492
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose requirement and effect of nicardipine on lipid profile in mild to moderate essential hypertensives.
    Tariq AR; Maheendran K; Kamsiah J; Christina P
    Med J Malaysia; 1992 Sep; 47(3):182-9. PubMed ID: 1491643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twice-daily nicardipine in the treatment of essential hypertension.
    Charlap S; Kimmel B; Laifer L; Weinberg P; Singer M; Lazar E; Saltzberg S; Dorsa F; Kafka K; Strom J
    J Clin Hypertens; 1986 Sep; 2(3):271-7. PubMed ID: 3537214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects on casual and 24-h ambulatory blood pressure of slow-release nicardipine and chlorthalidone in arterial essential hypertension: double-blind, crossover study.
    Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Divitiis O
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):190-6. PubMed ID: 2365538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diltiazem vs. nicardipine on ambulatory and exercise blood pressure and on peripheral hemodynamics.
    Palatini P; Casiglia E; Graniero GR; Dorigatti F; Lotoro F; Vriz O; Pessina AC
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):38-42. PubMed ID: 7711991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of slow-release nicardipine on blood pressure, renal function and the renin-angiotensin-aldosterone system in patients with mild-to-moderate essential arterial hypertension].
    Melina D; Guerrera G; Santoliquido A; Colivicchi F; Melina G; Musumeci V; Guerrera C
    Clin Ter; 1991 Nov 15-30; 139(3-4):101-6. PubMed ID: 1837249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nicardipine on the metabolic responses to food and exercise.
    Ahmed JH; Elliott HL; Hosie J; Farish E; Reid JL
    J Hum Hypertens; 1992 Apr; 6(2):139-44. PubMed ID: 1597847
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.